Condition
Human Immunodeficiency Virus (HIV) clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Human Immunodeficiency Virus (HIV) clinical trials that are recruiting, at sites in 6 countries (most in United States (5), Kenya (3), Canada (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1New in 30 days
- 6Countries
Newest Human Immunodeficiency Virus (HIV) clinical trials
All recruiting trials (10)
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Psilocybin Therapy for MeUD and HIV
This study tests whether a single psilocybin dose, paired with motivational support therapy, can help people with HIV and moderate-to-severe methamphetamine use disorder stop using methamphetamine.
-
Voluntary HIV screening among adults in France
This study will see which voluntary HIV testing methods adults in France use.
-
PrEP delivery led by HIV testing counselors in Kenyan clinics
A counselor-led approach is being tested to see if it helps deliver PrEP in public health clinics for people in Kenya who may be at risk for HIV.
-
Monthly MK-8527 to prevent HIV-1 infection
This study will test whether taking MK-8527 once a month prevents HIV-1 better than daily oral PrEP in HIV-negative, sexually active cisgender women.
-
Adding fostemsavir to reduce inflammation in people with well-controlled HIV
This trial will test whether adding fostemsavir to current HIV treatment lowers inflammation and heart disease risk for people with well-controlled HIV who have detectable sgp120.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
A program for transgender adults to support recovery from substance use and HIV risk
This study is testing a support program for transgender adults to see if it can help them reduce substance use and lower their risk of HIV.
-
Understanding how chronic stress affects brain and immune function in HIV positive individuals using stimulants
This study is testing how chronic stress affects the brain and immune system in people with HIV who use stimulants, to see if a new online program can help improve their health.
-
Optimizing a smoking cessation program for people living with HIV
This study is trying to find the best way to help people living with HIV quit smoking by using a mix of support methods like counseling, mentoring, and text reminders.
Related topics
Quick answers
How many Human Immunodeficiency Virus (HIV) clinical trials are recruiting right now?
10, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (5 trials), Kenya (3 trials), Canada (1 trial), South Africa (1 trial), Uganda (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.